|
YEAR 2007
June 19, 2007
COURT AFFIRMS PLAVIX® PATENT
May 24, 2007
APOTEX LAUNCHES GENERIC NORVASC®
March 21, 2007
APOTEX INVALIDATES NORVASC® PATENT
YEAR 2006
December 8, 2006
COURT
AFFIRMS INJUNCTION ON GENERIC PLAVIX® SALES
August 31, 2006
COURT HALTS SALES OF GENERIC PLAVIX®
August 8, 2006
APOTEX LAUNCHES FIRST GENERIC PLAVIX®
March 22, 2006
APOTEX ANNOUNCES AGREEMENT TO SETTLE U.S. PLAVIX(R) LITIGATION
February 1, 2006
APOTEX RECEIVES FINAL APPROVAL FOR DILTIAZEM HCL EXTENDED RELEASE CAPSULES
January
25, 2006
APOTEX RECEIVES
APPROVAL FOR FIRST GENERIC PLAVIX®
YEAR 2005
November
30, 2005
APOTEX RECEIVES FINAL APPROVAL FOR
OFLOXACIN OTIC 0.3%
September 14, 2005
APOTEX RECEIVES FINAL APPROVAL FOR LEFLUNOMIDE TABLETS
August 24, 2005
COURT RULES IN FAVOR OF APOTEX CORP. IN SUMMARY JUDGMENT DECISION REGARDING SALE OF GABAPENTIN
August 2, 2005
APPROVAL FOR CEFTRIAXONE INJECTION, APOTEX TO MARKET EXCLUSIVELY UNDER ORCHID AGREEMENT
May
19, 2005
APOTEX
RECEIVES FINAL APPROVAL FOR FOSINOPRIL SODIUM TABS
May
18, 2005
APOTEX
PRAISES APPEALS COURT OPINION OF ACULAR PATENT INVALIDITY
April
11, 2005
APOTEX
VICTORY IN GENERIC PAXIL® CASE CONFIRMED ONCE AGAIN
April
6, 2005
APOTEX
LAUNCHES GABAPENTIN CAPSULES
January
28, 2005
APOTEX
LAUNCHES HALOPERIDOL PRE-FILLED SYRINGE
January 27, 2005
APOTEX
LAUNCHES DESMOPRESSIN ACETATE NASAL SPRAY
YEAR 2004
December
2, 2004
APOTEX
NAMES BUDDY BERTUCCI NATIONAL SALES DIRECTOR, INSTITUTIONAL
October
13, 2004
APOTEX
RECEIVES FINAL APPROVALS FOR LISINOPRIL HCTZ TABLETS AND FLUMAZENIL
VIALS
October
7, 2004
APOTEX
NAMES DAVID D. DUNLOP VICE PRESIDENT OF MARKETING AND SALES
OPERATIONS
July
29, 2004
APOTEX
RECEIVES FINAL APPROVAL FOR FLUCONAZOLE TABLETS - COMPANY BEGINS
SHIPMENTS OF GENERIC VERSION OF DIFLUCAN®
July
15, 2004
APOTEX
LAUNCHES GENERIC SINEMET® CR TABLETS
May
14, 2004
APOTEX
LAUNCHES GENERIC OCUFLOX® OPHTHALMIC SOLUTION
April 26, 2004
APOTEX VICTORY IN GENERIC
PAXIL® CONFIRMED
YEAR 2003
November
12, 2003
APOTEX LAUNCHES GENERIC VERSION OF
PRILOSEC® CAPSULES
September 8, 2003
APOTEX LAUNCHES FIRST GENERIC VERSION OF
PAXIL® - AFFORDABLE PRODUCT KEPT FROM CONSUMERS FOR YEARS TOO LONG!
August
28, 2003
APOTEX CLEARED FOR LAUNCH OF GENERIC BETAPACE AF™
July
31, 2003
APOTEX GETS FINAL APPROVAL FOR GENERIC PAXIL® - FDA CLEARANCE ADVANCES COMPANY PLANS TO OFFER LOW-COST ALTERNATIVE
July 30, 2003
APOTEX LAUNCHES GENERIC EQUIVALENT TO CEFTIN® - COMPANY BEGINS SHIPMENTS OF POPULAR ANTIBIOTIC
June 1, 2003
APOTEX RECEIVES TENTATIVE APPROVAL FOR GENERIC VERSION OF ACULAR®
- COMPANY PLANS EXCLUSIVE LAUNCH PENDING FINAL APPROVAL
March
4, 2003
APOTEX WINS KEY BATTLE OVER GENERIC
PAXIL® - COURT VICTORY ON HEMIHYDRATE PATENT CLEARS KEY HURDLE
PRESS ARCHIVES
2002 Archive
2001 Archive
2000 Archive
1999 Archive
|
